Cargando…
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Since the arrival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, its characterization as a novel human pathogen, and the resulting coronavirus disease 2019 (COVID-19) pandemic, over 6.5 million people have died worldwide—a stark and sobering reminder of the fundame...
Autor principal: | Tangye, Stuart G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746792/ https://www.ncbi.nlm.nih.gov/pubmed/36522221 http://dx.doi.org/10.1016/j.jaci.2022.11.010 |
Ejemplares similares
-
SARS‐CoV‐2 infection and treatment in a cohort of patients with inborn errors of immunity
por: Conti, Francesca, et al.
Publicado: (2022) -
Flow Cytometric-Based Analysis of Defects in Lymphocyte Differentiation and Function Due to Inborn Errors of Immunity
por: Ma, Cindy S., et al.
Publicado: (2019) -
Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity
por: Johnson, Sarah, et al.
Publicado: (2023) -
Prolonged Fecal Shedding of SARS-CoV-2 in Asymptomatic Children with Inborn Errors of Immunity
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2021) -
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)